Paweł Marcin Wiśniewski

age 46

Currently 5 roles in 4 KRS entities. In the KRS since 2011.

Roles

EntityRole
4cell Therapies S.A.
  • President of the Management Board
since Jul 1, 2020
Instytut Analiz Genetycznych sp. z o.o.
  • President of the Management Board
  • Partner (56% of shares worth PLN 2,800)
since Sep 26, 2011
Orphinic Scientific S.A.
  • Supervisory Board Member
since Oct 30, 2023
Glia sp. z o.o.
  • Partner (10% of shares worth PLN 1,000)
since Jun 14, 2016

Connections graph

Change history

EventDetails
Liquidation opened

Partner. Resolution No. 3 of the extraordinary shareholders' meeting dated 29.12.2023 on dissolution of the company and opening of its liquidation; repertory A No. 41914/2023; notary Robert Błaszczak, notary office at pl. Bankowy 1, Warszawa. Liquidator: Anna Elżbieta Aranowska Bablok.

Glia sp. z o.o.
Role changed

Vice President of the Management Board → President of the Management Board

4cell Therapies S.A.
Share capital increased

Share capital: PLN 1,880,468.50 → PLN 2,065,653.70

4cell Therapies S.A.
Appointed

Supervisory Board Member

Orphinic Scientific S.A.
Shareholding changed

Partner: 80 shares worth PLN 4,000 → 56% of shares worth PLN 2,800

Instytut Analiz Genetycznych sp. z o.o.
Shareholding changed

Partner: 40 shares worth PLN 2,000 → 80 shares worth PLN 4,000

Instytut Analiz Genetycznych sp. z o.o.
Share capital increased

Share capital: PLN 1,321,950 → PLN 1,880,468.50

4cell Therapies S.A.
Share capital increased

Share capital: PLN 1,101,950 → PLN 1,321,950

4cell Therapies S.A.

Business scale

Total for the entities where the person sat on the management board or held shares, for the years in office.

Risk signals

SignalDetails
Politically exposed person (PEP)
None
Person on a sanctions list
None
Bankruptcy or restructuring
None
Liquidation
Sanctions list
None
Inactive entity
None

Connected people

Person
Adam Kruszewskiage 61
Agnieszka Pogorzelskaage 47
Artur Płonowskiage 61
Jarosław Jerzy Leszczyszynage 65
Paweł Grzegorz Leksage 50